OECD: CRISPR Agro-Biotech Ethics in 2026
OECD's 2026 report sets ethical rules for CRISPR agro-biotech investment. Learn why clear guidelines for gene-editing can secure $15B+ capital.
OECD's 2026 report sets ethical rules for CRISPR agro-biotech investment. Learn why clear guidelines for gene-editing can secure $15B+ capital.
US renewable energy goals are threatened by slow project permitting. Learn why bureaucratic delays risk 2026 targets and what's needed to speed up deploymen
Global biotech regulation stifles Syngenta's innovations, costing agriculture $10 billion annually. Learn why harmonized rules are critical.
Can Mexico's energy policy capitalize on 8.8 billion cubic meters of biomethane? See why incentives matter for sustainable investment.
Why do consumers and markets see 2026 inflation differently? This article explains the disconnect and its impact on your finances and Fed policy.
How can Mexico ensure its biomethane is truly green? Learn how rigorous verification and ISCC EU certification prevent greenwashing by 2026.
How Meridian Manufacturing fought a 2024 policy threat in Dalton, GA. See 5 key takeaways for businesses facing costly regulatory changes.
Will central banks prevent a 2026 bond crisis? This opinion reveals why current policy is complacent and what decisive action is needed now.
Expanding your business to the EU by 2026? Understand 4 key e-commerce regulations, from GDPR to VAT, to avoid penalties and succeed.
NYC's complex real estate taxes stifle growth. Will the city reform its 421-a abatement program to fix inequities and boost housing?